WAY-100635 is a potent dopamine D4 receptor agonist

被引：0
|
作者：
Benjamin R. Chemel
Bryan L. Roth
Blaine Armbruster
Val J. Watts
David E. Nichols
机构：
[1] Purdue University,Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmaceutical Sciences
[2] Psychiatry,Departments of Biochemistry
[3] Neurosciences and NIMH Psychoactive Drug Screening Program,undefined
[4] Case Western Reserve University Medical School,undefined
来源：
Psychopharmacology | 2006年 / 188卷
关键词：
WAY-100635; WAY-100634; 5-HT; D; D; Receptor selectivity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：244 / 251
页数：7
相关论文
共 50 条
  • [1] WAY-100635 is a potent dopamine D4 receptor agonist
    Chemel, Benjamin R.
    Roth, Bryan L.
    Armbruster, Blaine
    Watts, Val J.
    Nichols, David E.
    PSYCHOPHARMACOLOGY, 2006, 188 (02) : 244 - 251
  • [2] The "selective" 5-HT1A antagonist WAY-100635 and its metabolite, WAY-100634, are potent dopamine D4 receptor agonists
    Chemel, Benjamin R.
    Roth, Bryan L.
    Armbruster, Blaine
    Watts, Val J.
    Marona-Lewicka, Danuta
    Nichols, David E.
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S128 - S128
  • [3] WAY-100635 has high selectivity for serotonin 5-HT1A versus dopamine D4 receptors
    Martel, Jean-Claude
    Leduc, Nathalie
    Ormiere, Anne-Marie
    Faucillon, Valerie
    Danty, Nathalie
    Culie, Charlene
    Cussac, Didier
    Newman-Tancredi, Adrian
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 574 (01) : 15 - 19
  • [4] WAY 100635 produces discriminative stimulus effects in rats mediated by dopamine D4 receptor activation
    Marona-Lewicka, Danuta
    Nichols, David E.
    BEHAVIOURAL PHARMACOLOGY, 2009, 20 (01): : 114 - 118
  • [5] The discovery of potent and selective dopamine D4 receptor antagonists
    Faraci, WS
    Zorn, SH
    Sanner, MA
    Fliri, A
    CURRENT OPINION IN CHEMICAL BIOLOGY, 1998, 2 (04) : 535 - 540
  • [6] Moderate chemical modifications of WAY-100635 improve the selectivity for 5-HT1A versus D4 receptors
    Mangin, Floriane
    Dilly, Sebastien
    Joly, Benoit
    Scuvee-Moreau, Jacqueline
    Evans, Jon
    Setola, Vincent
    Roth, Bryan L.
    Liegeois, Jean-Francois
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (14) : 4550 - 4554
  • [7] A PHARMACOLOGICAL PROFILE OF WAY-100635, A POTENT AND SELECTIVE S-HT1A RECEPTOR ANTAGONIST
    FLETCHER, A
    BILL, DJ
    CLIFFE, IA
    FORSTER, EA
    JONES, D
    REILLY, Y
    BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 : U48 - U48
  • [8] Structural Insights into 5-HT1A/D4 Selectivity of WAY-100635 Analogues: Molecular Modeling, Synthesis, and in Vitro Binding
    Dilly, Sebastien
    Liegeois, Jean-Francois
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2016, 56 (07) : 1324 - 1331
  • [9] Resistance of the dopamine D4 receptor to agonist-induced internalization and degradation
    Spooren, Anneleen
    Rondou, Pieter
    Debowska, Katarzyna
    Lintermans, Beatrice
    Vermeulen, Linda
    Samyn, Bart
    Skieterska, Kamila
    Debyser, Griet
    Devreese, Bart
    Vanhoenacker, Peter
    Wojda, Urszula
    Haegeman, Guy
    Van Craenenbroeck, Kathleen
    CELLULAR SIGNALLING, 2010, 22 (04) : 600 - 609
  • [10] Dopamine D4 receptor ubiquitination
    Skieterska, Kamila
    Rondou, Pieter
    Van Craenenbroeck, Kathleen
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2016, 44 : 601 - 605
12345